VKTX News and Press, Viking Therapeutics Inc. From 05/13/24

2024-05-13 08:15:00 ET Viking Therapeutics (NASDAQ: VKTX) isn't a household name, but if its plans to commercialize a powerful anti-obesity medicine come to fruition, it may well become one. Though it has yet to commercialize a drug, unlike its primary big pharma competitors, the da...

2024-05-12 05:43:33 ET Summary Viking Therapeutics' subcutaneously administered version of VK2735 has generated competitive data in the phase 2 trial in obese patients. The oral formulation of VK2735 reported good tolerability that leaves room for exploration of higher doses. ...

2024-05-10 06:55:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investing in Russell 2000 stocks is a smart idea because it focuses on small-cap stocks with substantial growth potential. While individual stocks within the index vary, some are poised to ...

2024-05-10 03:40:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Global Advantage Fund gained 3.6% during the first quarter, compared to the 8.2%...

2024-05-09 09:14:53 ET Summary Viking Therapeutics, a clinical-stage company focused on metabolic and endocrine disorders, is primed for acquisition due to its robust pipeline and potential as a market disruptor. The company's pipeline includes innovative drugs targeting obesity, ...

2024-05-07 14:04:24 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Amid a challenging market environment, one of your best bets could be to target biotech stocks to buy. Yes, the sector can be volatile because much hinges on underlying breakthroughs. Never...

2024-05-03 10:28:54 ET More on Amgen Amgen, Inc. (AMGN) Q1 2024 Earnings Call Transcript Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet Amgen: I Prefer To Chase Value And Dividends Biggest stock movers today: WOW, AAPL, SQ, and more Amge...

2024-05-02 10:25:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. During the first quarter, Baron Opportunity Fund rose 15.33%, outperforming the broade...

2024-04-28 10:30:00 ET Viking Therapeutics (NASDAQ: VKTX) has emerged as a beacon of hope in an otherwise lackluster year for healthcare stocks. The buzz around its mid-stage weight loss candidate, VK2735, has propelled the biotech's stock to a staggering 714% surge since the comple...

2024-04-28 09:07:00 ET Viking Therapeutics (NASDAQ: VKTX) has been flying on all cylinders since the beginning of the year. The company's shares are up 246% due to excellent clinical progress. It's not rare for smaller biotechs to see their stock prices skyrocket relatively quickly,...